Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition.
Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition.
复制标题
DOI:
10.1371/journal.pone.0194183
复制
发表时间:
2018
期刊:
影响因子:
3.7
通讯作者:
Rickus JL
中科院分区:
文献类型:
--
作者:
Herrera-Perez RM;Voytik-Harbin SL;Sarkaria JN;Pollok KE;Fishel ML;Rickus JL
Despite the increasingly recognized importance of the tumor microenvironment (TME) as a regulator of tumor progression, only few in vitro models have been developed to systematically study the effects of TME on tumor behavior in a controlled manner. Here we developed a three-dimensional (3D) in vitro model that recapitulates the physical and compositional characteristics of Glioblastoma (GBM) extracellular matrix (ECM) and incorporates brain stromal cells such as astrocytes and endothelial cell precursors. The model was used to evaluate the effect of TME components on migration and survival of various patient-derived GBM cell lines (GBM10, GBM43 and GBAM1) in the context of STAT3 inhibition. Migration analysis of GBM within the 3D in vitro model demonstrated that the presence of astrocytes significantly increases the migration of GBM, while presence of endothelial precursors has varied effects on the migration of different GBM cell lines. Given the role of the tumor microenvironment as a regulator of STAT3 activity, we tested the effect of the STAT3 inhibitor SH-4-54 on GBM migration and survival. SH-4-54 inhibited STAT3 activity and reduced 3D migration and survival of GBM43 but had no effect on GBM10. SH-4-54 treatment drastically reduced the viability of the stem-like line GBAM1 in liquid culture, but its effect lessened in presence of a 3D ECM and stromal cells. Our results highlight the interplay between the ECM and stromal cells in the microenvironment with the cancer cells and indicate that the impact of these relationships may differ for GBM cells of varying genetic and clinical histories.
登录
查看更多内容
影响因子:
5.7
作者:
Arpin CC;Mac S;Jiang Y;Cheng H;Grimard M;Page BD;Kamocka MM;Haftchenary S;Su H;Ball DP;Rosa DA;Lai PS;Gómez-Biagi RF;Ali AM;Rana R;Hanenberg H;Kerman K;McElyea KC;Sandusky GE;Gunning PT;Fishel ML
通讯作者:
Fishel ML
影响因子:
11.2
作者:
Bonavia R;Inda MM;Cavenee WK;Furnari FB
通讯作者:
Furnari FB
影响因子:
8
作者:
Kesanakurti, D.;Chetty, C.;Maddirela, D. Rajasekhar;Gujrati, M.;Rao, J. S.
通讯作者:
Rao, J. S.
影响因子:
50.3
作者:
Hanahan, Douglas;Coussens, Lisa M.
通讯作者:
Coussens, Lisa M.
影响因子:
15.9
作者:
Dolecek, Therese A.;Propp, Jennifer M.;Kruchko, Carol
通讯作者:
Kruchko, Carol